Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antimalarials | 10 | 2017 | 903 | 1.540 |
Why?
|
| Plasmodium falciparum | 12 | 2017 | 1723 | 1.320 |
Why?
|
| Aminolevulinic Acid | 1 | 2023 | 139 | 0.840 |
Why?
|
| Electron Transport Complex II | 3 | 2012 | 52 | 0.600 |
Why?
|
| Xanthenes | 2 | 2013 | 73 | 0.490 |
Why?
|
| Naphthoquinones | 1 | 2014 | 59 | 0.490 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2017 | 1349 | 0.450 |
Why?
|
| Aminopeptidases | 1 | 2013 | 93 | 0.430 |
Why?
|
| Oxazines | 2 | 2013 | 315 | 0.420 |
Why?
|
| Staining and Labeling | 2 | 2013 | 1091 | 0.360 |
Why?
|
| Cell Survival | 5 | 2017 | 5761 | 0.310 |
Why?
|
| Plasmodium | 1 | 2011 | 244 | 0.310 |
Why?
|
| Inhibitory Concentration 50 | 6 | 2017 | 458 | 0.280 |
Why?
|
| Parasitic Sensitivity Tests | 3 | 2016 | 86 | 0.240 |
Why?
|
| Oocysts | 2 | 2012 | 18 | 0.210 |
Why?
|
| High-Throughput Screening Assays | 4 | 2017 | 925 | 0.210 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 4 | 2009 | 70 | 0.210 |
Why?
|
| Hep G2 Cells | 4 | 2017 | 386 | 0.200 |
Why?
|
| Structure-Activity Relationship | 8 | 2016 | 3077 | 0.190 |
Why?
|
| Plasmodium yoelii | 2 | 2012 | 42 | 0.190 |
Why?
|
| Malaria | 4 | 2016 | 1200 | 0.180 |
Why?
|
| Phosphates | 1 | 2023 | 761 | 0.170 |
Why?
|
| Receptors, Neuropeptide Y | 2 | 2009 | 46 | 0.170 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 2019 | 40 | 0.170 |
Why?
|
| Receptors, Histamine H3 | 2 | 2009 | 11 | 0.170 |
Why?
|
| Imidazoles | 2 | 2016 | 1165 | 0.170 |
Why?
|
| Microtubule Proteins | 1 | 2019 | 62 | 0.170 |
Why?
|
| Histamine Agonists | 2 | 2008 | 13 | 0.160 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2019 | 92 | 0.160 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 11839 | 0.150 |
Why?
|
| Babesia | 1 | 2017 | 29 | 0.150 |
Why?
|
| Naphthyridines | 1 | 2017 | 131 | 0.140 |
Why?
|
| Genome, Protozoan | 1 | 2017 | 143 | 0.140 |
Why?
|
| Small Molecule Libraries | 3 | 2017 | 719 | 0.140 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 880 | 0.130 |
Why?
|
| Iron | 1 | 2023 | 1735 | 0.120 |
Why?
|
| Cilia | 1 | 2019 | 488 | 0.120 |
Why?
|
| Chemistry, Pharmaceutical | 3 | 2014 | 275 | 0.120 |
Why?
|
| Saquinavir | 1 | 2013 | 29 | 0.110 |
Why?
|
| Gametogenesis | 1 | 2013 | 26 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 1348 | 0.110 |
Why?
|
| Parasites | 2 | 2013 | 162 | 0.110 |
Why?
|
| Ketotifen | 1 | 2012 | 23 | 0.110 |
Why?
|
| Genes, Protozoan | 1 | 2013 | 165 | 0.110 |
Why?
|
| Schistosomiasis mansoni | 1 | 2013 | 90 | 0.110 |
Why?
|
| Quinolones | 1 | 2016 | 375 | 0.110 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2012 | 32 | 0.100 |
Why?
|
| Schistosoma mansoni | 1 | 2013 | 153 | 0.100 |
Why?
|
| Molecular Structure | 5 | 2017 | 1877 | 0.100 |
Why?
|
| Gene Targeting | 2 | 2012 | 838 | 0.100 |
Why?
|
| Hepatitis B e Antigens | 1 | 2012 | 132 | 0.100 |
Why?
|
| Nevirapine | 1 | 2013 | 270 | 0.100 |
Why?
|
| Succinic Acid | 1 | 2012 | 84 | 0.100 |
Why?
|
| Thermus thermophilus | 1 | 2011 | 22 | 0.100 |
Why?
|
| Fumarates | 1 | 2012 | 138 | 0.100 |
Why?
|
| Primaquine | 1 | 2011 | 28 | 0.100 |
Why?
|
| Plasmodium berghei | 1 | 2012 | 159 | 0.100 |
Why?
|
| HIV Protease Inhibitors | 1 | 2013 | 434 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1567 | 0.090 |
Why?
|
| Protozoan Proteins | 3 | 2012 | 827 | 0.090 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2011 | 234 | 0.090 |
Why?
|
| Oxathiins | 1 | 2009 | 1 | 0.090 |
Why?
|
| Guanosine Diphosphate | 1 | 2009 | 79 | 0.090 |
Why?
|
| Cyclohexylamines | 1 | 2009 | 21 | 0.090 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2013 | 620 | 0.090 |
Why?
|
| DNA Transposable Elements | 1 | 2013 | 749 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 4576 | 0.080 |
Why?
|
| NADH Dehydrogenase | 1 | 2008 | 45 | 0.080 |
Why?
|
| 4-Aminopyridine | 1 | 2009 | 80 | 0.080 |
Why?
|
| Detergents | 1 | 2009 | 233 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 1879 | 0.080 |
Why?
|
| Mutagenesis | 1 | 2013 | 1223 | 0.080 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2008 | 24 | 0.080 |
Why?
|
| Artemisinins | 1 | 2011 | 216 | 0.080 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2009 | 102 | 0.080 |
Why?
|
| Cyclohexanes | 1 | 2009 | 149 | 0.080 |
Why?
|
| Guanosine Triphosphate | 1 | 2009 | 314 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2012 | 945 | 0.080 |
Why?
|
| Spiro Compounds | 1 | 2008 | 72 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1779 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 568 | 0.080 |
Why?
|
| Benzofurans | 1 | 2008 | 140 | 0.080 |
Why?
|
| Malaria, Falciparum | 2 | 2013 | 1063 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2193 | 0.070 |
Why?
|
| Quinazolinones | 1 | 2008 | 222 | 0.070 |
Why?
|
| HIV-2 | 1 | 2007 | 156 | 0.070 |
Why?
|
| Drug Discovery | 1 | 2014 | 1055 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 1945 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 1031 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2011 | 1187 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 2183 | 0.060 |
Why?
|
| Organelles | 1 | 2006 | 267 | 0.060 |
Why?
|
| Animals | 16 | 2019 | 166331 | 0.060 |
Why?
|
| Mitochondria | 2 | 2008 | 3523 | 0.060 |
Why?
|
| Narcotic Antagonists | 1 | 2009 | 558 | 0.060 |
Why?
|
| Hepacivirus | 1 | 2011 | 1364 | 0.060 |
Why?
|
| Cell Line | 6 | 2017 | 15631 | 0.060 |
Why?
|
| Polyethylene Glycols | 1 | 2009 | 1170 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2009 | 857 | 0.060 |
Why?
|
| Capsid Proteins | 1 | 2007 | 468 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 1541 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3153 | 0.050 |
Why?
|
| Genomics | 1 | 2017 | 5694 | 0.050 |
Why?
|
| Drug Repositioning | 2 | 2014 | 229 | 0.050 |
Why?
|
| Mice | 8 | 2019 | 80087 | 0.050 |
Why?
|
| Humans | 21 | 2023 | 746044 | 0.040 |
Why?
|
| Drug Design | 3 | 2009 | 1055 | 0.040 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2019 | 95 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2013 | 23112 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 53218 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2013 | 6095 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2007 | 2818 | 0.040 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2008 | 133 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2019 | 279 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 1885 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2011 | 3784 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 699 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2013 | 4406 | 0.040 |
Why?
|
| Models, Chemical | 2 | 2009 | 614 | 0.040 |
Why?
|
| Administration, Oral | 3 | 2009 | 3966 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 10718 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 1140 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2011 | 2503 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 6508 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 523 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2012 | 2905 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2011 | 7785 | 0.030 |
Why?
|
| Plasmodium cynomolgi | 1 | 2012 | 3 | 0.030 |
Why?
|
| NF-kappa B | 2 | 2012 | 2461 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 344 | 0.030 |
Why?
|
| Mutation | 3 | 2013 | 29614 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 371 | 0.030 |
Why?
|
| Flavoproteins | 1 | 2012 | 40 | 0.030 |
Why?
|
| Rats | 4 | 2009 | 23680 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2013 | 555 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 3784 | 0.030 |
Why?
|
| Lymphocyte Antigen 96 | 1 | 2011 | 19 | 0.030 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2011 | 46 | 0.020 |
Why?
|
| Proton-Motive Force | 1 | 2011 | 8 | 0.020 |
Why?
|
| Models, Biological | 3 | 2013 | 9443 | 0.020 |
Why?
|
| Periplasm | 1 | 2011 | 39 | 0.020 |
Why?
|
| Pedigree | 1 | 2019 | 4555 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4858 | 0.020 |
Why?
|
| Anti-Allergic Agents | 1 | 2012 | 148 | 0.020 |
Why?
|
| Protein Unfolding | 1 | 2011 | 56 | 0.020 |
Why?
|
| Asparagine | 1 | 2011 | 119 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2019 | 2044 | 0.020 |
Why?
|
| Anopheles | 1 | 2013 | 187 | 0.020 |
Why?
|
| Static Electricity | 1 | 2011 | 264 | 0.020 |
Why?
|
| Pulmonary Circulation | 1 | 2013 | 742 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2013 | 595 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2011 | 140 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 650 | 0.020 |
Why?
|
| Cholates | 1 | 2009 | 4 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 554 | 0.020 |
Why?
|
| Germ Cells | 1 | 2013 | 628 | 0.020 |
Why?
|
| Receptors, Opioid | 1 | 2009 | 143 | 0.020 |
Why?
|
| Hepatitis B virus | 1 | 2012 | 512 | 0.020 |
Why?
|
| Haplorhini | 1 | 2009 | 532 | 0.020 |
Why?
|
| Caspases | 1 | 2011 | 879 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2009 | 617 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2011 | 510 | 0.020 |
Why?
|
| Protein Binding | 2 | 2011 | 9278 | 0.020 |
Why?
|
| Family | 1 | 2019 | 3156 | 0.020 |
Why?
|
| Biological Transport | 1 | 2012 | 2077 | 0.020 |
Why?
|
| Electron Transport | 1 | 2008 | 209 | 0.020 |
Why?
|
| Oxygen | 1 | 2019 | 4175 | 0.020 |
Why?
|
| Plasmids | 1 | 2013 | 2275 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2014 | 1599 | 0.020 |
Why?
|
| Protein Stability | 1 | 2009 | 563 | 0.020 |
Why?
|
| Arginine | 1 | 2011 | 929 | 0.020 |
Why?
|
| Cricetulus | 1 | 2009 | 817 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 1540 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 578 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2006 | 301 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 2046 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2008 | 488 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2006 | 252 | 0.020 |
Why?
|
| CHO Cells | 1 | 2009 | 1393 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 1970 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 2326 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 2426 | 0.020 |
Why?
|
| Computational Biology | 1 | 2017 | 3484 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2019 | 12208 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 1960 | 0.020 |
Why?
|
| Hyperalgesia | 1 | 2009 | 500 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 1980 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2007 | 567 | 0.020 |
Why?
|
| Serotonin | 1 | 2009 | 1028 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 17834 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2012 | 2662 | 0.010 |
Why?
|
| Ligands | 1 | 2011 | 3266 | 0.010 |
Why?
|
| Dogs | 1 | 2009 | 3820 | 0.010 |
Why?
|
| Female | 4 | 2019 | 382109 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14211 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 2192 | 0.010 |
Why?
|
| Male | 3 | 2019 | 351093 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 2563 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2012 | 2397 | 0.010 |
Why?
|
| Smoking | 1 | 2019 | 8975 | 0.010 |
Why?
|
| Brain | 4 | 2009 | 26596 | 0.010 |
Why?
|
| Kinetics | 1 | 2009 | 6352 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9310 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2012 | 2836 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5379 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9441 | 0.010 |
Why?
|
| Lung | 1 | 2019 | 9842 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 8125 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20142 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 9421 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 21529 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 214412 | 0.010 |
Why?
|
| Peptides | 1 | 2007 | 4313 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16245 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 6420 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 164236 | 0.000 |
Why?
|
| Adult | 1 | 2019 | 214958 | 0.000 |
Why?
|
Concepts
(217)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_